Immuneering Corp (IMRX)
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Address
245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA 02142
Founded
2008
Number of Employees
68
Website
http://www.immuneering.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)